Fidelity Investments’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $740M | Buy |
|
|||||
|
2021
Q1 | $539M | Sell |
|
|||||
|
2020
Q4 | $982M | Sell |
|
|||||
|
2020
Q3 | $1.12B | Sell |
|
|||||
|
2020
Q2 | $1.46B | Buy |
|
|||||
|
2020
Q1 | $1.07B | Sell |
|
|||||
|
2019
Q4 | $1.59B | Sell |
|
|||||
|
2019
Q3 | $1.92B | Sell |
|
|||||
|
2019
Q2 | $3.35B | Sell |
|
|||||
|
2019
Q1 | $3.94B | Buy |
|
|||||
|
2018
Q4 | $2.57B | Buy |
|
|||||
|
2018
Q3 | $2.93B | Buy |
|
|||||
|
2018
Q2 | $2.42B | Buy |
|
|||||
|
2018
Q1 | $2.15B | Buy |
|
|||||
|
2017
Q4 | $2.11B | Sell |
|
|||||
|
2017
Q3 | $2.66B | Sell |
|
|||||
|
2017
Q2 | $2.6B | Sell |
|
|||||
|
2017
Q1 | $3.27B | Sell |
|
|||||
|
2016
Q4 | $3.45B | Buy |
|
|||||
|
2016
Q3 | $3.04B | Buy |
|
|||||
|
2016
Q2 | $2.19B | Buy |
|
|||||
|
2016
Q1 | $2.33B | Buy |
|
|||||
|
2015
Q4 | $2.84B | Buy |
|
|||||
|
2015
Q3 | $2.27B | Sell |
|
|||||
|
2015
Q2 | $2.7B | Sell |
|
|||||
|
2015
Q1 | $3.41B | Sell |
|
|||||
|
2014
Q4 | $4.1B | Buy |
|
|||||
|
2014
Q3 | $3.33B | Buy |
|
|||||
|
2014
Q2 | $2.77B | Sell |
|
|||||
|
2014
Q1 | $3.15B | Buy |
|
|||||
|
2013
Q4 | $2.6B | Sell |
|
|||||
|
2013
Q3 | $2.32B | Buy |
|
|||||
|
2013
Q2 | $1.55B | Buy |
|